ASTS
AST SpaceMobile, Inc.
ASTS has a slight edge over CNXC overall, supported by stronger fundamentals and stronger modeled upside.
CNXC
Concentrix Corporation
CNXC has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CNXC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Under pressure |
CNXC's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CNXC PE Valuation
CNXC has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CNXC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect CNXC's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over CNXC on earnings, with more consistent year-over-year improvement.
CNXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.51 | — |
| Q3 2026 | -$38.42 | -912% |
| Q2 2026 | -$20.84 | -673% |
| Q1 2026 | -$21.07 | -628% |
| Q4 2025 | -$20.36 | -649% |
| Q3 2025 | $4.73 | +57% |
| Q2 2025 | $3.64 | -14% |
| Q1 2025 | $3.99 | -17% |
| Q4 2024 | $3.71 | -35% |
CNXC has swung to a loss: it lost $38.42 per share over the past year, after a profit the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CNXC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CNXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.5B | -1.2% |
| Q2 2026 | $2.5B | +1.9% |
| Q1 2026 | $2.5B | +5.4% |
| Q4 2025 | $2.6B | +4.3% |
| Q3 2025 | $2.5B | +4% |
| Q2 2025 | $2.4B | +1.5% |
| Q1 2025 | $2.4B | -1.3% |
| Q4 2024 | $2.4B | +9.7% |
CNXC's revenue grew through 2024 and has held roughly level since: $2.5B last quarter, down 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -37% | -43 points |
| Q2 2026 | 3.9% | -2.3 points |
| Q1 2026 | 4.7% | -2.4 points |
| Q4 2025 | -54% | -60 points |
| Q3 2025 | 5.9% | -0.5 points |
| Q2 2025 | 6.1% | -0.2 points |
| Q1 2025 | 7.1% | +0.9 points |
| Q4 2024 | 5.9% | -2.2 points |
CNXC has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CNXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.2M | +38% |
| Q2 2026 | $209.7M | +16% |
| Q1 2026 | -$137.1M | -$87.9M |
| Q4 2025 | $281.2M | +25% |
| Q3 2025 | $159.7M | +24% |
| Q2 2025 | $180.7M | +1.4% |
| Q1 2025 | -$49.2M | +$53.7M |
| Q4 2024 | $224.5M | +37% |
CNXC has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CNXC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +48K shares |
| 1 year | -2.9% | -1.8M shares |
| 3 years | +19% | +9.7M shares |
| 5 years | +17% | +8.8M shares |
| Available history | +19% | +9.8M shares |
CNXC has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $43.2M |
| Q4 2025 | $55.9M |
| Q3 2025 | $41.6M |
| Q2 2025 | $45.3M |
| Q1 2025 | $25.8M |
| Q4 2024 | $34.5M |
CNXC spent $99M buying back its own shares over the past year, down 33% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CNXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.2x | High |
| Q3 2024 | 4.7x | High |
| Q2 2024 | 5.4x | High |
| Q1 2024 | 5.6x | High |
| Q4 2023 | 5.6x | High |
CNXC's net debt is about 3.5 years of its operating earnings (EBITDA), down from 4.7 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CNXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.3 | Neutral |
| Stochastic | 68.9 | Neutral |
CNXC's weekly RSI is 56 (neutral) and its Stochastic is 69 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CNXC PE vs Technology Sector
| Metric | CNXC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CNXC has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CNXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.9 | 11% above |
| 20 week MA | $27.1 | 18% above |
| 50 week MA | $30.3 | 5.7% above |
| 100 week MA | $39.7 | 19% below |
| 200 week MA | $60.0 | 47% below |
CNXC has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CNXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.0 | $99.9 | +25% |
| 2021 | $99.9 | $177.2 | +77% |
| 2022 | $177.2 | $129.6 | -27% |
| 2023 | $129.6 | $98.2 | -24% |
| 2024 | $98.2 | $44.4 | -55% |
| 2025 | $44.4 | $42.0 | -5.6% |
| 2026 YTD | $42.0 | $32.0 | -24% |
CNXC has the edge over ASTS on returns for 2026, with the stronger performance.